NZ543347A - Use of phenoxyacetic acid derivatives for treating hyperactive bladder - Google Patents

Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Info

Publication number
NZ543347A
NZ543347A NZ543347A NZ54334704A NZ543347A NZ 543347 A NZ543347 A NZ 543347A NZ 543347 A NZ543347 A NZ 543347A NZ 54334704 A NZ54334704 A NZ 54334704A NZ 543347 A NZ543347 A NZ 543347A
Authority
NZ
New Zealand
Prior art keywords
group
acid
use according
hydroxy
amino
Prior art date
Application number
NZ543347A
Other languages
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ543347(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NZ543347A publication Critical patent/NZ543347A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ543347A 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder NZ543347A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
PCT/JP2004/004048 WO2004098586A1 (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Publications (1)

Publication Number Publication Date
NZ543347A true NZ543347A (en) 2008-05-30

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ543347A NZ543347A (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Country Status (26)

Country Link
US (1) US20040229947A1 (https=)
EP (1) EP1620085B1 (https=)
JP (1) JP4602969B2 (https=)
KR (1) KR101052804B1 (https=)
AR (1) AR044169A1 (https=)
AT (1) ATE401878T1 (https=)
AU (1) AU2004236596B2 (https=)
BR (1) BRPI0409980A (https=)
CA (1) CA2524023C (https=)
CL (1) CL2004000952A1 (https=)
CY (1) CY1108425T1 (https=)
DE (1) DE602004015272D1 (https=)
DK (1) DK1620085T3 (https=)
ES (1) ES2309513T3 (https=)
IL (1) IL171713A (https=)
MX (1) MXPA05011862A (https=)
MY (1) MY141756A (https=)
NZ (1) NZ543347A (https=)
PE (1) PE20050524A1 (https=)
PL (1) PL1620085T3 (https=)
PT (1) PT1620085E (https=)
RU (1) RU2342133C2 (https=)
SI (1) SI1620085T1 (https=)
TW (1) TWI351279B (https=)
UY (1) UY28306A1 (https=)
WO (1) WO2004098586A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
CA2605298A1 (en) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
US7763654B2 (en) * 2005-04-26 2010-07-27 Kissei Pharmaceutical Co., Ltd. Crystal polymorph of hydroxynorephedrin derivative hydrochloride
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
EP4410295A3 (en) 2017-06-06 2024-10-16 Urovant Sciences GmbH Use of vibegron to treat overactive bladder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
US6410484B1 (en) * 1999-11-01 2002-06-25 Sumitomo Chemical Company, Limited 6-Hydroxy-5,6-dihydrouracil compound and herbicidal composition containing thereof
MXPA04002449A (es) * 2001-09-13 2004-07-23 Kissei Pharmaceutical Cristales de derivado de hidroxinorefedrina.

Also Published As

Publication number Publication date
ES2309513T3 (es) 2008-12-16
EP1620085A1 (en) 2006-02-01
CA2524023C (en) 2011-11-22
EP1620085B1 (en) 2008-07-23
CY1108425T1 (el) 2014-04-09
JP4602969B2 (ja) 2010-12-22
KR101052804B1 (ko) 2011-07-29
IL171713A (en) 2011-12-29
JP2006525318A (ja) 2006-11-09
DK1620085T3 (da) 2008-11-24
CA2524023A1 (en) 2004-11-18
US20040229947A1 (en) 2004-11-18
PE20050524A1 (es) 2005-07-07
CL2004000952A1 (es) 2005-03-04
WO2004098586A1 (en) 2004-11-18
PT1620085E (pt) 2008-08-07
ATE401878T1 (de) 2008-08-15
AU2004236596B2 (en) 2010-03-11
SI1620085T1 (sl) 2008-12-31
AR044169A1 (es) 2005-08-24
RU2005137701A (ru) 2006-06-10
UY28306A1 (es) 2004-12-31
KR20060009886A (ko) 2006-02-01
MXPA05011862A (es) 2006-02-17
MY141756A (en) 2010-06-30
RU2342133C2 (ru) 2008-12-27
DE602004015272D1 (de) 2008-09-04
TW200509902A (en) 2005-03-16
PL1620085T3 (pl) 2009-01-30
BRPI0409980A (pt) 2006-05-09
TWI351279B (en) 2011-11-01
AU2004236596A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
JP5263170B2 (ja) 過活動膀胱治療用医薬組成物
PL211687B1 (pl) Środek leczniczy przeznaczony do leczenia nadmiernie aktywnego pęcherza moczowego, zawierający jako składnik aktywny pochodną acetanilidu
AU2004236596B2 (en) Use of phenoxyacetic acid derivatives for treating hyperactive bladder
JP2007534771A (ja) 炎症性疾患の治療におけるフェノキシアルキルカルボン酸誘導体
US20050101607A1 (en) Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitor
US7008939B2 (en) Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence
AU2002223688B2 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
ZA200508825B (en) Use of phenoxyacetic acid derivatives for treating hyperactive bladder
EP1652532A1 (en) Medicinal composition
US20100261770A1 (en) Pharmaceutical composition for improving lower urinary tract symptoms
CN104302293A (zh) 用于压力性尿失禁的预防剂和/或治疗剂
US20070129435A1 (en) Pharmaceutical Composition For Treating Stress Incontinence And/Or Mixed Incontinence

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed